(Q43169262)

15 November 2017

Enumeration and phenotypic assessment of human plasmacytoid and myeloid dendritic cells in whole blood (English)

1 reference

15 November 2017

1 reference

2

1 reference

15 November 2017

Ferdousi Chowdhury

1

1 reference

PubMed ID

20140969

15 November 2017

Anthony Peter Williams

series ordinal

3

1 reference

PubMed ID

20140969

15 November 2017

language of work or name

1 reference

1 April 2010

1 reference

15 November 2017

1 reference

15 November 2017

77

1 reference

15 November 2017

4

1 reference

15 November 2017

328-337

1 reference

The multiple personalities of the chemokine receptor CCR7 in dendritic cells

15 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20872

Reduced blood BDCA-2+ (lymphoid) and CD11c+ (myeloid) dendritic cells in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20872

7 January 2021

Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20872

7 January 2021

Peripheral-blood dendritic cells in men with coronary heart disease.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20872

7 January 2021

Characterization of circulating blood dendritic cell subsets DC123+ (Lymphoid) and DC11C+ (myeloid) in prostate adenocarcinoma patients

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20872

7 January 2021

Reduced numbers of plasmacytoid dendritic cells in aged blood donors

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20872

7 January 2021

Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20872

7 January 2021

Development of dendritic-cell lineages

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20872

7 January 2021

Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20872

7 January 2021

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20872

7 January 2021

Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20872

7 January 2021

Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20872

7 January 2021

Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20872

7 January 2021

Bioanalytical method validation--a revisit with a decade of progress

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20872

7 January 2021

Four-fold staining including CD45 gating improves the sensitivity of multiparameter flow cytometric assessment of minimal residual disease in patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20872

7 January 2021

Discriminant function analysis as decision support system for the diagnosis of acute leukemia with a minimal four color screening panel and multiparameter flow cytometry immunophenotyping.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20872

7 January 2021

Incidence, sensitivity, and specificity of leukemia-associated phenotypes in acute myeloid leukemia using specific five-color multiparameter flow cytometry.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20872

7 January 2021

Validation and quality control of immunophenotyping in clinical flow cytometry

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20872

7 January 2021

Validation and comparison of two multiplex technologies, Luminex and Mesoscale Discovery, for human cytokine profiling

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20872

7 January 2021

Biomarker method validation in anticancer drug development

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20872

7 January 2021

Workshop on bioanalytical methods validation for macromolecules: summary report

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20872

7 January 2021

Bioanalytical method validation for macromolecules in support of pharmacokinetic studies

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20872

7 January 2021

Influence of EDTA and heparin on lipopolysaccharide binding and cell activation, evaluated at single-cell level in whole blood.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20872

7 January 2021

A whole blood assay to assess peripheral blood dendritic cell function in response to Toll-like receptor stimulation

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20872

7 January 2021

Peripheral blood manipulation significantly affects the result of dendritic cell monitoring

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20872

7 January 2021

Freeze-thawing procedures have no influence on the phenotypic and functional development of dendritic cells generated from peripheral blood CD14+ monocytes.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20872

7 January 2021

CD83 expression is a sensitive marker of activation required for B cell and CD4+ T cell longevity in vivo

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20872

7 January 2021

CD83 regulates lymphocyte maturation, activation and homeostasis.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20872

7 January 2021

CCR7 and its ligands: balancing immunity and tolerance

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20872

7 January 2021

Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20872

7 January 2021

LPS/TLR4 signal transduction pathway

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20872

7 January 2021

Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20872

7 January 2021

Toll-like receptor function and signaling

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20872

7 January 2021

Monitoring dendritic cells in clinical practice using a new whole blood single-platform TruCOUNT assay

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20872

7 January 2021

Reduced frequency of peripheral plasmacytoid dendritic cells in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20872

7 January 2021

Absolute count and percentage of CD4+ lymphocytes are independent predictors of disease progression in HIV-infected persons initiating highly active antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20872

7 January 2021

Flow cytometric detection of circulating dendritic cells in healthy subjects

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20872

7 January 2021

U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: data analysis and interpretation

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20872

7 January 2021

Application of six-color flow cytometry for the assessment of dendritic cell responses in whole blood assays

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20872

7 January 2021

Identifiers

DOI

10.1002/CYTO.A.20872

1 reference

15 November 2017

1 reference

PubMed ID

20140969